BAI – Senior Manager, Global Oncology Forecasting Lead
Amgen
Summary
The Forecasting team at Amgen plays a pivotal role as a strategic partner to commercial leadership, offering data-backed insights crucial for driving commercial success. This role is instrumental in driving commercial success and shaping future strategies for our oncology pipeline assets.
Job description
The Global Oncology Forecasting Lead will be responsible for leading the forecasting efforts for pipeline assets and diseases within the Global Oncology business unit. The individual in this role will work with individual product/brand forecasters to develop cross-brand insights, ensure quality/consistency, drive adoption of best practices, coach & mentor junior forecasters, and help distill forecasting analytics into concise, executive worthy strategic recommendations for the brand team.
Strategic Insights and Recommendations
- Support leadership in identifying actionable strategies to improve commercial potential and prioritize key risks & opportunities.
- Provide informed recommendations & rationale on product go / no-go decisions based on relevant factors such as market conditions, financial projections, and strategic goals.
- Present forecast recommendations and insights to leadership in a concise, straightforward manner, centered on business dynamics rather than modeling nuances.
Communication and Presentation
- Work with product/brand forecasting leads to deliver transparent presentations articulating the key forecast variables and revenue implications.
- Develop brand & portfolio-level analyses & recommendations appropriate for a VP level audience.
- Use communication and interpersonal skills to help shape key brand decisions and recommended course of action.
Advanced Forecasting Techniques
- Support & coach forecasters on the development of detailed and advanced forecast models projecting units and revenue for our oncology pipeline products by indication/regions.
- Use advanced simulation models (e.g., Monte Carlo analysis, statistical trending) to quantify uncertainty within a brand and across the Global Oncology portfolio.
- Leverage in-depth knowledge of diverse pharmaceutical data sources (e.g., LAAD, National Audit Rx, Xponent, Epidemiology data sources, etc.) and their nuances to enhance forecasting approaches and methodologies.
- Lead methodology & best practice development and ensure consistency across multiple brand forecasts.
- Lead roll-out of novel centralized forecasting platform.
Collaboration and Stakeholder Engagement
- Collaborate with the broader BAI organization to ensure product/brand forecasters have access to comprehensive insights and analytics relevant to their work.
- Improve the depth and accuracy of forecasts by leveraging a broad spectrum of insights across the organization.
- Explore AI/ML and automation; identify team capability gaps and build skills.
- Owns multi-brand forecasts; challenges entrenched assumptions; drives process improvements across cycles.
Process Optimization
- Drive productivity and efficiency by standardizing forecasting processes where possible.
- Oversee deliverables across brands/assets and ensure quality.
Requirements
- Doctorate degree and 2 years of Pharma/Biotech forecasting, demand planning, or supply chain management experience OR Master’s degree and 4 years of Pharma/Biotech forecasting, demand planning, or supply chain management experience OR Bachelor’s degree and 6 years of Pharma/Biotech forecasting, demand planning, or supply chain management experience OR Associate’s degree and 10 years of Pharma/Biotech forecasting, demand planning, or supply chain management experience OR High school diploma / GED and 12 years of Pharma/Biotech forecasting, demand planning, or supply chain management experience
- Prior experience in oncology
- 6+ years of forecasting, market research, or business analytics experience in the biopharmaceutical or healthcare industries
- Ability to quickly establish credibility with and influence ED/VP level staff
- Strong project management skills—able to organize and complete multiple projects efficiently and on time
- Understanding of the latest developments in the biopharmaceutical industry, and unmet medical needs and opportunities in oncology
- Experience with advanced forecasting techniques, patient based forecast modeling (including dynamic patient flow models), and experience doing analog and uptake curve analysis
- Experience with quantitative techniques including smoothing, regression, time series analysis, and simulation
- Working knowledge of forecasting inputs and structure, global access and reimbursement policies, competitive environment and potential impact on product development and commercialization strategy
- Broad, working knowledge of commonly used biopharmaceutical industry databases such as IQVIA, Symphony Health, Flatiron, EMR, Optum, Truven, McKesson, DRG and other large datasets that require custom analysis and evaluation
- Highly skilled in working collaboratively in a team-based environment and gaining alignment across an organization
- High level of proficiency in Excel, PowerPoint, Word
- Excellent communication skills with the ability to present complex data and insights to both technical and non-technical partners, including senior management
- Ability to interpret and analyze data trends, identify patterns, and make data-driven decisions
- Experience in contributing to the development of long-term business plans based on forecasting insights
Benefits
- Retirement and Savings Plan
- Medical, Dental & Vision
- Life and Disability Insurance
- Flexible Spending Accounts
- Discretionary Annual Bonus
- Stock-based Long-term Incentives
- Paid Time Off
- Flexible Work Models
Company overview
Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.